Park Avenue Securities’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
7,561
-1,965
-21% -$73K ﹤0.01% 1536
2026
Q1
$381K Sell
9,526
-1,629
-15% -$77.1K ﹤0.01% 1215
2025
Q4
$509K Sell
11,155
-58
-0.5% -$2.68K ﹤0.01% 1084
2025
Q3
$497K Sell
11,213
-1,744
-13% -$83.5K ﹤0.01% 1188
2025
Q2
$622K Buy
12,957
+3,856
+42% +$168K 0.01% 966
2025
Q1
$361K Buy
9,101
+440
+5% +$18.5K ﹤0.01% 950
2024
Q4
$397K Buy
8,661
+2,106
+32% +$94.3K ﹤0.01% 1173
2024
Q3
$304K Buy
+6,555
New +$299K ﹤0.01% 1174

Other funds holding QGEN

Park Avenue Securities's QGEN Position: Q2 2026 in Review

Park Avenue Securities reduced its Qiagen (QGEN) stake by 21% in Q2 2026, selling an estimated $73K and leaving 7,561 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Park Avenue Securities first reported a position in QGEN in Q3 2024 and has held it in 8 quarters since. The position peaked at $622K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Park Avenue Securities held 7,561 shares of Qiagen worth $293K as of Q2 2026.
  • Park Avenue Securities sold 1,965 Qiagen shares in Q2 2026, an estimated $73K.
  • Qiagen made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1536 holding.
  • Park Avenue Securities first reported a position in Qiagen in Q3 2024 and has held it in 8 quarters since.
  • Park Avenue Securities's Qiagen position peaked at $622K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.